0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

TREATMENT OF CHRONIC DISCOID LUPUS ERYTHEMATOSUS WITH CHLOROQUINE (ARALEN)

Donald M. Pillsbury, M.D.; Coleman Jacobson, M.D.
JAMA. 1954;154(16):1330-1333. doi:10.1001/jama.1954.02940500010004.
Text Size: A A A
Published online

The treatment of discoid cutaneous lupus erythematosus was, until recently, very unsatisfactory. The disease not infrequently persists for many years, with intermittent exacerbations and partial remissions unrelated to any particular type of treatment. The only measure of regular value has been avoidance of exposure to sunlight. The effectiveness of the most commonly used treatment, injections of gold and sodium thiosulfate, is so equivocal in the experience of one of us (D. M. P.) that we have not used it at all for at least 12 years. The drug is toxic, and in patients with disseminated visceral lupus erythematosus, its ill-advised administration has sometimes produced disastrous results. The effectiveness of various compounds containing bismuth or arsenic has not been demonstrated without question; certainly any effects they have on discoid lupus erythematosus are feeble. Local destructive procedures, such as the use of carbon dioxide snow, are useful only in a small percentage

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();